About Stephen Glover
Stephen Glover is a chief executive officer and director at ZyVersa Therapeutics.
Form D filings name Stephen Glover as a board member at BioGene Therapeutics.
Stephen Glover reports to the SEC as a director or officer of 7 public companies, including Oncolytics Biotech (ONCY), PDS Biotechnology (PDSB) and Ambrx Biopharma (AMAM).
Stephen Glover first appears on SEC filings in 2006.
Experience
This experience comes from Stephen Glover's profile and from SEC filings. For roles taken from filings, the years are when the filings name Stephen Glover in the role, so the role may have started earlier or lasted longer.
ZI
ZyVersa Therapeutics, Inc. Current
Executive officer
Co-Founder, Chairman and Chief Executive Officer (2014 – Present)
2014 – Present · Public company (ZVSA)
BioGene Therapeutics Inc.
Board Member
2026 · Austin, TX
Develops gene therapies for people with diabetes and obesity.
OI
Oncolytics Biotech Inc.
Director
2026 · Public company (ONCY)
PC
PDS Biotechnology Corp
Director
2019 – 2026 · Public company (PDSB)
AI
Ambrx Biopharma, Inc.
Director
2024 · Public company (AMAM)
AI
Ambrx Biopharma Inc.
Director
2023 · Public company (AMAM)
CB
Coherus BioSciences
Co-Founder, Chief Business Officer
2010 – 2013
II
Insmed Inc.
President Follow-on Biologics
President and Chief Business Officer (2006 – 2010)
2006 – 2010 · Public company (INSM)
AI
Auriga Laboratories, Inc.
Director
2006 · Public company (ARGA)
AN
Andrx
Senior Vice President and General Manager Andrx Laboratories
2003 – 2006
Key Colleagues at Startups
The people Stephen Glover works with at each company, as listed on that company's latest Form D.
BioGene Therapeutics Inc. · Form D, Aug 7, 2026
DH
David Howton
Director
Stephen Van Deventer
Chief Executive Officer & President, director
Raj Pruthi
Independent Director
Patroski Lawson
Independent Director
Deepak Sampath
Independent Director